GJB2 and psoriasis: CX26 and Ki67 levels were increased with a decrease in E-cadherin protein expression, suggesting this model could be further developed to dissect the impact of drugs targeting connexin related pathways and environmental triggers on patho-physiological mechanisms leading to psoriasis [61].